Clinical Trial Update: Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.

View source ↗

Summary

A clinical trial update describing real-world effectiveness of abrocitinib in adults with moderate-to-severe atopic dermatitis who had inadequate response to pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Cibinqo (abrocitinib)

Snippet

Sponsor: Pfizer | Conditions: Atopic Dermatitis, Atopic Dermatitis, Unspecified | Status: RECRUITING